![Lucas Donigian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lucas Donigian
Corporate Officer/Principal chez ZYMEWORKS INC.
Provenance du réseau au premier degré de Lucas Donigian
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 28 | |
Public Company | Biotechnology | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lucas Donigian via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Founder Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO Chief Tech/Sci/R&D Officer Public Communications Contact | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
University of British Columbia | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Presidio Pharmaceuticals, Inc.
![]() Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Sanofi-Aventis U.S. LLC
![]() Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
RELYPSA INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
British Columbia Bar Association
![]() British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Michigan | College/University | Doctorate Degree Masters Business Admin | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Think Forwards | Corporate Officer/Principal Chief Executive Officer | ||
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Doctorate Degree | |
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
AFFYMAX, INC. | Biotechnology | Director/Board Member Chairman | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
American Society of Hematology
![]() American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
University of Pennsylvania | College/University | Doctorate Degree | |
SUMMIT THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
FOUNDATION MEDICINE INC | Medical/Nursing Services | Chief Executive Officer | |
Biosplice Therapeutics, Inc.
![]() Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
STANDARD BIOTOOLS INC. | Miscellaneous Commercial Services | Chairman | |
Massachusetts Biotechnology Council
![]() Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
LetsGetChecked, Inc.
![]() LetsGetChecked, Inc. Medical SpecialtiesHealth Technology LetsGetChecked, Inc. operates online platform which connects customers and diagnostic laboratories. It offers its diagnostics services for general health, sexual health, cancer screening and fertility and hormone check. The company was founded by Peter Foley in 2014 and is headquartered in Dun Laoghaire, Ireland. | Medical Specialties | Director/Board Member | |
SOPHIA GENETICS SA | Packaged Software | Chairman | |
UCB Biopharma SRL
![]() UCB Biopharma SRL Medical DistributorsDistribution Services Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting. | Medical Distributors | Corporate Officer/Principal | |
Dream Foundation | Director/Board Member | ||
Lengo Therapeutics, Inc.
![]() Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Aventis, Inc. | Corporate Officer/Principal | ||
UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Kentucky | College/University | Undergraduate Degree | |
Society For Immunotherapy of Cancer
![]() Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services The Society for Immunotherapy of Cancer (SITC) is an organization that advances the science, development, and application of immunotherapy to improve cancer patient outcomes. The non-profit company is based in Milwaukee, WI. SITC conducts policy and advocacy efforts on behalf of its members and the field. The Journal for Immunotherapy of Cancer (JITC) is the official open access, peer-reviewed online journal of SITC, featuring original research articles, literature reviews, position papers, and discussions on all aspects of tumor immunology and cancer immunotherapy. SITC also created a conceptual framework for potential value in phase III studies evaluating immunotherapy combinations. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Missouri | College/University | Masters Business Admin | |
ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
Etats-Unis | 41 |
Canada | 8 |
Belgique | 3 |
Suisse | 2 |
Sectorielle
Health Technology | 28 |
Consumer Services | 10 |
Commercial Services | 7 |
Health Services | 3 |
Finance | 2 |
Opérationnelle
Director/Board Member | 173 |
Corporate Officer/Principal | 83 |
Independent Dir/Board Member | 61 |
Chief Tech/Sci/R&D Officer | 34 |
Undergraduate Degree | 30 |
Relations les plus connectées
Insiders | |
---|---|
Nicholas G. Galakatos | 38 |
Ken Galbraith | 30 |
Kenneth Bailey | 23 |
Susan Mahony | 21 |
Donald Kania | 21 |
Lota Zoth | 20 |
Alessandra Cesano | 19 |
Troy Cox | 19 |
Hollings Renton | 17 |
Kelvin Neu | 15 |
Elena Viboch | 14 |
Natalie Sacks | 13 |
Ali Tehrani | 13 |
Diana Hausman | 13 |
Carlos Campoy | 10 |
- Bourse
- Insiders
- Lucas Donigian
- Connexions Sociétés